Nalaganje...
Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity
Major obstacles in immunotherapies include toxicities associated with systemic administration of therapeutic agents, as well as low tumor lymphocyte infiltration that hampers the efficacies. In this study, we report a mesenchymal stem cell (MSC)-based immunotherapeutic strategy in which MSCs specifi...
Shranjeno v:
| izdano v: | Mol Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Gene & Cell Therapy
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7704751/ https://ncbi.nlm.nih.gov/pubmed/32827461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.08.005 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|